Page 27 - Read Online

Potdar CTCs in cancer diagnosis and treatment

mutations in FGR-R genes in CTCs can be considered Ethics approval
as a diagnostic marker in bladder cancer. Similarly, This article does not contain any studies with human
TWIST and vimentin are considered as diagnostic participants or animals.
markers for hepatocellular carcinoma. Häfner et al.
[14]
have isolated CTCs from metastatic cervical cancer REFERENCES
patients and evaluated levels of HPV16-E6 mRNA by
real-time PCR, as a more sensitive molecular marker 1. Ashworth TR. A case of cancer in which cells similar to those in the
than CK19 mRNA. At the same time, Kuhlmann et al. tumors were seen in the blood after death. Aus Med J 1869;14:146-9.
[15]
have shown that ERCC1+ CTCs can predict platinum 2. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW,
resistance therapy in ovarian cancer. Overall, it Uhr JW. Detection and characterization of carcinoma cells in the

seems that molecular profiling of CTCs is becoming a 3. blood. Proc Natl Acad Sci U S A 1998;95:4589-94.
Marrinucci D, Bethel K, Kolatkar A, Luttgen MS, Malchiodi M,
popular tool for diagnosis and therapies of solid tumor Baehring F, Voigt K, Lazar D, Nieva J, Bazhenova L, Ko AH, Korn
malignancies. WM, Schram E, Coward M, Yang X, Metzner T, Lamy R, Honnatti
M, Yoshioka C, Kunken J, Petrova Y, Sok D, Nelson D, Kuhn P. Fluid
CLINICAL APPLICATIONS OF CTCS biopsy in patients with metastatic prostate, pancreatic and breast
ANALYSIS 4. cancers. Phys Biol 2012;9:016003.
Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS,
Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur
Recently, analysis of CTCs in the blood of metastatic R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M,
cancer patients has received enormous attention Haber DA, Maheswaran S. Circulating tumor cell clusters are oligo
because of its very important clinical applications in clonal precursors of breast cancer metastasis. Cell 2014;158:1110-22.
personalized medicine. [16] Several investigators have 5. Mikolajczyk SD, Millar LS, Tsinberg P, Coutts SM, Zomorrodi M,
studied CTCs derived from breast cancer patients Pham T, Bischoff FZ, Pircher TJ. Detection of EpCAM-negative and
cytokeratin-negative circulating tumor cells in peripheral blood. J
for diagnosis and treatment of breast cancer. They Oncol 2011;2011:252361.
have shown direct correlation of CTCs with disease 6. Potdar PD, Lotey NK. Review: circulating tumor cells in future diagnosis
prognosis and survival, and shown that the greater the and therapies of cancer. J Cancer Metastasis Treat 2015;1:44-56.
number of CTCs, the lower the chances of survival. 7. Krawczyk N, Meier-Stiegen F, Banys M, Neubauer H, Ruckhaeberle
The CellSearch system, FDA-approved, is most E, Fehm T. Expression of stem cell and epithelial-mesenchymal
®
commonly used for enumeration of CTCs in these transition markers in circulating tumor cells of breast cancer patients.
experiments, which are mainly based on positive Biomed Res Int 2014;2014:415721.
expression of EpCAM and CK protein on the surface 8. Chen CL, Osmulski P, Mahalingum D, Horning AM, Jadhav RR,
Louie AD, Wang CM, Huang THM. Abstract 5588: epithelial-to-
of these cells. However, this may limit the selection mesenchymal markers of circulating tumour cells for detection of
[17]
due to the EMT transition process undergoing in CTCs castration-resistant prostate cancer. Cancer Res 2014;74:5588.
during the metastatic process of cancer, in which there 9. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS,
is a downregulation of EpCAM surface protein. The Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur
CTCs values are measured before and after chemo- R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M, Haber
or radiotherapies and treatment can be determined by DA, Maheswaran S. Circulating tumour cell clusters are oligoclonal
precursors of breast cancer metastasis. Cell 2014;158:1110-22.
greater or lesser CTCs counts in patients. Peeters et al. 10. Swaby RF, Cristofanilli M. Circulating tumor cells in breast cancer: a
[18]
have shown that patients with more than 80 CTCs in tool whose time has come of age. BMC Med 2011;9:43.
7.5 mL blood died within one year following diagnosis 11. Dittamore R, Louw J, Krupa R, Anand A, Danila DC, ArslanZ, Bales
of metastases. CTCs analysis is very much useful N, Marrinucci D, Scher HI. Molecular characterization of circulating
[18]
in understanding stages of various cancers. Overall tumour cells (CTC) and CTC subpopulations in baseline and
this suggests that CTCs enumeration and molecular progressive metastatic castration resistant prostate cancer (mCRPC).
profiling with proper follow-up can determine the J Clin Oncol 2014;32:e16018.
aggressiveness of cancers, which could help clinicians 12. Schölch S, Bork U, Rahbari NN, García S, Swiersy A, Betzler AM,
Weitz J, Koch M. Circulating tumor cells of colorectal cancer. Cancer
decide more efficacious and targeted treatments for Cell Microenviron 2014;1:1-5.
management of metastatic cancer patients. 13. Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani
F, Polanski R, Burt DJ, Simpson KL, Morris K, Pepper SD, Nonaka
Financial support and sponsorship D, Greystoke A, Kelly P, Bola B, Krebs MG, Antonello J, Ayub M,
Nil. Faulkner S, Priest L, Carter L, Tate C, Miller CJ, Blackhall F, Brady
G, Dive C. Tumorigenicity and genetic profiling of circulating tumor
cells in small-cell lung cancer. Nat Med 2014;20:897-903.
Conflicts of interest 14. Häfner N, Gajda M, Altgassen C, Hertel H, Greinke C, Hillemanns P,
There are no conflicts of interest. Schneider A, Dürst M. HPV16-E6 mRNA is superior to cytokeratin 19
mRNA as a molecular marker for the detection of disseminated tumour
Patient consent cells in sentinel lymph nodes of patients with cervical cancer by
There is no patient involved. quantitative reverse-transcription PCR. Int J Cancer 2007;120:1842-6.
4 Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ January 12, 2017